BCTXW
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$0.00
−0.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -44.4%
- EBIT
- -46.7%
- EPS
- —
- Free cash flow
- -68.4%
- Operating cash flow
- -68.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -14.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jan 1, 2026